<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915392</url>
  </required_header>
  <id_info>
    <org_study_id>7122</org_study_id>
    <nct_id>NCT03915392</nct_id>
  </id_info>
  <brief_title>Diffusion Weighted MRI Accuracy in Cholesteatoma Localization</brief_title>
  <acronym>CHOLEMRI</acronym>
  <official_title>Diffusion Weighted MRI Accuracy in Cholesteatoma Localization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Magnetic resonance imaging of the middle ear has an increasing place in the therapeutic&#xD;
      strategy in otology and especially for cholesteatoma. It is currently performed for&#xD;
      complicated cholesteatomas and as part of the follow-up of operated patients to detect a&#xD;
      recurrence or a cholesteatoma residue (alternative of choice to &quot;second look&quot; surgery). Some&#xD;
      people take CT and MRI fusion to improve the localization of cholesteatoma. Many studies have&#xD;
      investigated the diagnostic capabilities of MRI but very few have demonstrate their&#xD;
      reliability in location diagnosis. The aim of the study was to propose a topographic reading&#xD;
      method of the MRI of the middle ear and to evaluate the performances in the localization of&#xD;
      the cholesteatoma in order to adapt the surgical management&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MRI imaging study to locate cholesteatoma.</measure>
    <time_frame>The period from January 1st, 2010 to Dcember 31, 2017 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cholesteatoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent cholesteatoma surgery between January 1, 2010 and December 31, 2017&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        inclusion criteria&#xD;
&#xD;
          -  Age: from 1 month and up&#xD;
&#xD;
          -  Sex: man / woman&#xD;
&#xD;
          -  Patient who had a tympanoplasty in closed technique, for the first surgical time of a&#xD;
             cholesteatoma or for residual or recurrent cholesteatoma, performed by the same&#xD;
             radiologist (Pr Anne Charpiot) with the following characteristics:&#xD;
&#xD;
               -  Code of the Common Classification of Medical Acts (CCAM)&#xD;
&#xD;
                    -  Exeresis of cholesteatoma with tympanoplasty in closed technique and&#xD;
                       ossiculoplasty (CBFA002)&#xD;
&#xD;
                    -  Exeresis of cholesteatoma with tympanoplasty in closed technique (CBFA006)&#xD;
&#xD;
                    -  Exeresis of cholesteatoma confined to the tympanic cavity without&#xD;
                       antro-attic exploration (CBFA005)&#xD;
&#xD;
                    -  Tympanoplasty in closed technique with posterior tympanotomy (CBMD001)&#xD;
&#xD;
                    -  Secondary tympanoplasty in closed technique (CBMD002)&#xD;
&#xD;
               -  Diagnostic code of the International Classification of Diseases (ICD10)&#xD;
&#xD;
                    -  Cholesteatoma of the middle ear (H71)&#xD;
&#xD;
          -  Diagnosis of macroscopic and / or pathological cholesteatoma.&#xD;
&#xD;
          -  Preoperative diagnosis of cholesteatoma on MRI of the middle ear performed in less&#xD;
             than 6 months by the same radiologist (Pr Francis Veillon).&#xD;
&#xD;
          -  Subject (or the holders of parental authority in the case of minors) having agreed to&#xD;
             the use of medical data for the purpose of this research.&#xD;
&#xD;
        Cholesteatoma is a very common disease in the pediatric population, with important&#xD;
        functional issues, whose treatment is surgical. That's why our study includes minor&#xD;
        subjects.&#xD;
&#xD;
        Criteria of non-inclusion&#xD;
&#xD;
          -  Refusal of the patient to participate in the study&#xD;
&#xD;
          -  Absence of data concerning the diagnosis and / or localization of cholesteatoma on the&#xD;
             operative record&#xD;
&#xD;
          -  Subject under the protection of justice&#xD;
&#xD;
          -  Subject under guardianship or curatorship&#xD;
&#xD;
          -  Pregnancy (woman of childbearing age)&#xD;
&#xD;
          -  Breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne CHARPIOT, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne CHARPIOT, MD, PhD</last_name>
    <phone>33 3 88 12 76 49</phone>
    <email>anne.charpiot@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoine MERANGER, MD</last_name>
    <phone>33 3 88 12 76 49</phone>
    <email>antoine.meranger@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service D'Orl Et de Chirurgie Cervico-Faciale</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne CHARPIOT, MD, PhD</last_name>
      <phone>33 3 88 12 76 49</phone>
      <email>anne.charpiot@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Antoine MERANGER, MD</last_name>
      <phone>33 3 88 12 76 49</phone>
      <email>antoine.meranger@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Anne CHARPIOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine MERANGER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 14, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diffusion weighted MRI</keyword>
  <keyword>Cholesteatoma</keyword>
  <keyword>Localization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholesteatoma</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

